Drug Profile
ALGRX 1207
Alternative Names: 1207; ALGRX-1207Latest Information Update: 22 Jan 2007
Price :
$50
*
At a glance
- Originator Anesiva
- Class Anaesthetics; Analgesics
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anaesthesia; Neuropathic pain
Most Recent Events
- 18 Jan 2007 Discontinued - Phase-I for Anaesthesia in Australia (Topical)
- 18 Jan 2007 Discontinued - Preclinical for Anaesthesia in USA (Topical)
- 18 Jan 2007 Discontinued - Preclinical for Neuropathic pain in USA (Topical)